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INTRODUCTION
In reality, in most of sub-Saharan Africa, either COVID-19 tests (1) are unavailable or turnaround
time is long or results take too long to return from distant laboratories (2). Even for tests now
done at local laboratories, the turnaround time is longer because of the volume, frequent stockouts
of reagent and sample collection kits, and power cuts. For example, in Cross River State in
South-Eastern Nigeria (population 3.7 million) as of December 13, 2020, only 1993 COVID-19
RT-PCR tests have reportedly been performed since the pandemic onset (at centralized sites of the
National Centre for Disease Control) (3). This situation suits the politico-economic drivers to ease
lockdown restrictions, but creates a false sense of security. Some symptoms of COVID-19 overlap
with those of common infections such as malaria, dengue, and pneumonia, making diagnosis
challenging without a test.
HOW ACCURATE ARE COVID-19 RT-PCR TESTS?
The COVID-19 RT-PCR test has a sensitivity of 71–98% (4), equating to false-negative rates of
2–29% and high specificity, though accuracy of testing is dependent on the quality of sampling and
when in the course of illness the sample is collected. It is difficult for clinicians (and more so for the
public) to understand how COVID-19 RT-PCR tests could give false-negative results—especially in
week 1 of the illness (5) with grave consequences if people then fail to follow preventive measures.
The question then arises, “How can diagnosis of COVID-19 be improved in resource-
constrained settings with limited diagnostic testing capacity?” The answer is that there is an urgent
need instead for a clinical diagnostic algorithm (based on symptoms, available laboratory tests and
chest X-rays). Such an algorithm will guide decisions to treat and give preventive advice including
home isolation and quarantine of close family/contacts. Ideally, this tool would also have sensitivity
and specificity close to that of the RT-PCR test in week 1 of COVID-19 disease. The algorithm
should include asking for symptoms (questions about loss of taste/smell in addition to other more
diverse symptoms, contact and co-morbidities), assessing severity of the disease (using CRB65 or
NEWS score), identifying suspected cases, and prescribing appropriate care (Appendix 1).
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PREDICTIVE VALUE OF CLINICAL
SYMPTOMS FOR DIAGNOSING COVID-19
It is recognized that certain constellations of symptoms can
have predictive value when diagnosing suspected COVID-19,
and these can be used in diagnostic and decision-making tools.
The current WHO clinical case definition uses “acute respiratory
illness,” i.e., fever and a respiratory symptom such as cough or
shortness of breath (6). A recent study involving 803 health
care workers found that the most frequently reported symptoms
among PCR-positive cases were headache, malaise, and myalgia.
Anosmia (loss of sense of smell) was 23 times more likely in
the PCR-positive group (7). Similarly, another study found that
anosmia (excluding those with nasal congestion) had a specificity
of around 97% and a sensitivity of 68% for COVID-19 positivity
(8). Clinical features can also predict who might become severely
ill with COVID-19 or require ICU care. Dyspnea was the best
predictor of severe COVID-19 and COPD and cardiovascular
diseases were the comorbidities most often found in severely ill
patients (9).
DISCUSSION
A diagnostic algorithm incorporating these symptoms and
signs, along with available parameters such as lymphopenia,
or bilateral peripheral opacities on plain chest x-ray, could be
a way of making care decisions in suspected COVID-19 (a
disease which will be around for some time). Advice could
then be given on isolation measures and home quarantine
for contacts of the case. Also, a patient record capturing this
information could be used for clinical case reporting and to
assist local disease control efforts. The algorithm should also
recognize the diagnostic uncertainty in the outpatient setting
in the absence of reliable tests and should therefore signpost
actions that also safely manage other likely causes of illness, for
example, antibiotics for possible bacterial pneumonia if patients
have a fever and/or raised respiratory rate, or antimalarials for
patients with a positive malaria parasite test. COVID-19 testing
is recommended, but where there is limited access, this does not
delay the care and prevention response.
The COVID-19 diagnostic algorithm could be incorporated
into guidelines, such as the concise guide we have developed for
health facility practitioners that has been made available online
(9) as free continuing professional development trainingmodules
in Nigeria, promoted through the state health offices. It provides
operational guidelines for providing care of patients with possible
COVID-19 while continuing other essential care and prevention
and focuses on screening, isolation, treatment, and infection
prevention and control. The COVID-19 guide was added to a
National Institute for Health Research (NIHR)-funded project to
test online training of a national guideline for non-communicable
diseases. Nurses from 20 primary health care centers in Cross
River State received the online training and showed a marked
improvement in their pre/post training scores.
In conclusion, rather than the current reality that
pretends that timely COVID-19 tests are available while
turning a blind eye to ongoing COVID-19 community
transmission and failing to protect the people, a concise
and user-friendly clinical algorithm should be deployed
for COVID-19 suspects in the absence of a diagnostic
test. This should use common presenting symptoms and
easily accessible investigations to predict likely COVID-19
cases, while acknowledging the diagnostic uncertainty and
directing the safe management of diseases with overlapping
presentations. This would facilitate the timely provision of
appropriate advice on prevention and isolation strategies and
provide a case surveillance mechanism to inform local disease
control response.
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